Image of the Day: Lumbar Support

An experimental tissue engineering treatment that addresses damage at both the inner core and outer ring of sheep intervertebral discs improves spinal structure and function.

Written byAmy Schleunes
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Discectomy, a surgical procedure that involves the removal of part or all of an intervertebral disc, is often recommended for people with herniated discs that limit their mobility and cause chronic pain. Research has suggested that 90 percent of Americans will experience intervertebral disc degeneration during their lifetime, and though discectomies may relieve symptoms in some patients, they don’t prevent further disc degeneration and herniation. In a new study published on March 11 in Science Translational Medicine, the authors use a sheep model, which bears many similarities to the human lumbar spine, to test a tissue engineering procedure designed to restore and repair the spine after discectomy.

Eight sheep underwent partial discectomies in which their nucleus pulposus, the soft inner core of the intervertebral disc, was removed. They then received either a hyaluronic acid injection into the inner intervertebral disc, a collagen patch on the outer intervertebral disc, or both ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies